Characteristics of finasteride users in comparison with nonusers: A Nordic nationwide study based on individual-level data from Denmark, Finland, and Sweden

Thora Majlund Kjærulff; Annette Kjær Ersbøll; Eero Pukkala; Kristian Bolin; Anders Green; Martha Emneus; Klaus Brasso; Peter Iversen; Lau Caspar Thygesen

doi:10.1002/pds.4947

Characteristics of finasteride users in comparison with nonusers: A Nordic nationwide study based on individual-level data from Denmark, Finland, and Sweden

Thora Majlund Kjærulff
, Annette Kjær Ersbøll
, Eero Pukkala
, Kristian Bolin
, Anders Green
, Martha Emneus
, Klaus Brasso
, Peter Iversen
, Lau Caspar Thygesen

Terveystieteet

Tutkimustuotos: Artikkeli › Tieteellinen › vertaisarvioitu

1 Sitaatiot (Scopus)

Alkuperäiskieli	Englanti
Sivut	453-460
Julkaisu	Pharmacoepidemiology and Drug Safety
Vuosikerta	29
Numero	4
DOI - pysyväislinkit	https://doi.org/10.1002/pds.4947
Tila	Julkaistu - 2020
OKM-julkaisutyyppi	A1 Alkuperäisartikkeli tieteellisessä aikakauslehdessä

YK:n kestävän kehityksen tavoitteet

Tämä tuotos edistää seuraavia kestävän kehityksen tavoitteita:

SDG 3 – Hyvä terveys ja hyvinvointi

Tutkimusalat

finasteride
pharmacoepidemiology
registries
surveys and questionnaires

Julkaisufoorumi-taso

Jufo-taso 1

Pääsy asiakirjaan

10.1002/pds.4947

http://urn.fi/URN:NBN:fi:tuni-202005205510

Siteeraa tätä

Kjærulff, T. M., Ersbøll, A. K., Pukkala, E., Bolin, K., Green, A., Emneus, M., Brasso, K., Iversen, P., & Thygesen, L. C. (2020). Characteristics of finasteride users in comparison with nonusers: A Nordic nationwide study based on individual-level data from Denmark, Finland, and Sweden. Pharmacoepidemiology and Drug Safety, 29(4), 453-460. https://doi.org/10.1002/pds.4947

@article{001b14f0600e4ccbba05c5770873f102,

title = "Characteristics of finasteride users in comparison with nonusers: A Nordic nationwide study based on individual-level data from Denmark, Finland, and Sweden",

keywords = "finasteride, pharmacoepidemiology, registries, surveys and questionnaires, finasteride, pharmacoepidemiology, registries, surveys and questionnaires",

author = "Kj{\ae}rulff, \{Thora Majlund\} and Ersb{\o}ll, \{Annette Kj{\ae}r\} and Eero Pukkala and Kristian Bolin and Anders Green and Martha Emneus and Klaus Brasso and Peter Iversen and Thygesen, \{Lau Caspar\}",

year = "2020",

doi = "10.1002/pds.4947",

language = "English",

volume = "29",

pages = "453--460",

journal = "Pharmacoepidemiology and Drug Safety",

issn = "1053-8569",

publisher = "John Wiley \& Sons",

number = "4",

}

Kjærulff, TM, Ersbøll, AK, Pukkala, E, Bolin, K, Green, A, Emneus, M, Brasso, K, Iversen, P & Thygesen, LC 2020, 'Characteristics of finasteride users in comparison with nonusers: A Nordic nationwide study based on individual-level data from Denmark, Finland, and Sweden', Pharmacoepidemiology and Drug Safety, Vuosikerta 29, Nro 4, Sivut 453-460. https://doi.org/10.1002/pds.4947

Characteristics of finasteride users in comparison with nonusers: A Nordic nationwide study based on individual-level data from Denmark, Finland, and Sweden. / Kjærulff, Thora Majlund; Ersbøll, Annette Kjær; Pukkala, Eero et al.
julkaisussa: Pharmacoepidemiology and Drug Safety, Vuosikerta 29, Nro 4, 2020, s. 453-460.

Tutkimustuotos: Artikkeli › Tieteellinen › vertaisarvioitu

TY - JOUR

T1 - Characteristics of finasteride users in comparison with nonusers: A Nordic nationwide study based on individual-level data from Denmark, Finland, and Sweden

AU - Kjærulff, Thora Majlund

AU - Ersbøll, Annette Kjær

AU - Pukkala, Eero

AU - Bolin, Kristian

AU - Green, Anders

AU - Emneus, Martha

AU - Brasso, Klaus

AU - Iversen, Peter

AU - Thygesen, Lau Caspar

PY - 2020

Y1 - 2020

KW - finasteride

KW - pharmacoepidemiology

KW - registries

KW - surveys and questionnaires

KW - finasteride

KW - pharmacoepidemiology

KW - registries

KW - surveys and questionnaires

U2 - 10.1002/pds.4947

DO - 10.1002/pds.4947

M3 - Article

SN - 1053-8569

VL - 29

SP - 453

EP - 460

JO - Pharmacoepidemiology and Drug Safety

JF - Pharmacoepidemiology and Drug Safety

IS - 4

ER -